New treatment approaches in multiple myeloma.
Berrebi
Alain
A
Hematology Institute, Kaplan Medical Center, Rehovot, Israel. berrebi@agri.huji.ac.il
D000368:Aged; D001897:Boronic Acids / Q000627:therapeutic use*; D000069286:Bortezomib; D003226:Congresses as Topic; D005260:Female; D006801:Humans; D015994:Incidence; D007557:Israel / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy* / Q000453:epidemiology / Q000503:physiopathology; D011480:Protease Inhibitors / Q000627:therapeutic use*; D011719:Pyrazines / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D033581:Stem Cell Transplantation; D013792:Thalidomide / Q000627:therapeutic use
D001897:Boronic Acids; D011480:Protease Inhibitors; D011719:Pyrazines; D013792:Thalidomide; D000069286:Bortezomib